Cite
HARVARD Citation
Rocca, A. et al. (2021). Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Therapeutic advances in medical oncology. p. . [Online].